Fred Hutch's Obliteride sets new fundraising record

News Releases

Fred Hutch's Obliteride sets new fundraising record

The bike ride to obliterate cancer raises $2.65 million for local cancer research

From this year's Obliteride.

Courtesy of Obliteride

Click for high-res version

SEATTLE, Oct. 29, 2015 – Fred Hutch’s Obliteride climbs to a record $2.65 million in its third year, bringing in more money for a nonprofit organization than any other bike ride in the Pacific Northwest. To date, Obliteride has raised nearly $7 million for lifesaving cancer research at Fred Hutchinson Cancer Research Center.

“Our riders are passionate about helping Fred Hutch cure cancer,” said Amy Lavin, Obliteride’s executive director. “We’re thrilled to see the community rally to support the world-class research center we have right here in Seattle.”

Nearly 1,200 people rode more than 63,000 miles in the August event. “Obliteride is more than a bike ride,” said Lavin. “It’s a fun weekend of concerts, celebration and connection around a common goal.”

“Thank you to everyone who helped raise these funds that are so vital to our work toward cancer cures,” said Dr. Gary Gilliland, president and director of Fred Hutch. “There’s a very real urgency now as we are on the cusp of real breakthroughs in cancer research. Fundraising efforts like Obliteride help us answer the most promising questions faster.”

Where does the money go?

Obliteride donations will support various forms of cancer research, including immunotherapy, breast cancer and other solid-tumor cancers. A portion of Obliteride funds also will be designated to catalyze some of the newest and most promising cancer research.

Obliteride’s generous sponsors, including University Village and the Sloan Foundation, ensure 100 percent of every dollar raised goes directly to research at Seattle’s Fred Hutch.

Obliteride 2016

Want to be part of this exciting event? Save the date for the next Obliteride: Aug. 14, 2016. Registration opens in the spring. For more information, visit www.obliteride.org.

ABOUT OBLITERIDE

Obliteride is maniacally focused on FUNding cancer research at Fred Hutch and ultimately, ending cancer. We ride together annually, focusing on possibilities, embracing our fears and celebrating discovery. It’s fun, focused and full of energy! Learn more at www.obliteride.org.

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.

CONTACT
Kerri Kazarba Schneider
Obliteride Media Relations
206.288.3332
kerri@obliteride.org